Shionogi, JP3347200002

Shionogi reports EU Zokovea approval: what it means for Shionogi stock

Published on 10/02/2026 at 05:05 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

EU approval came on September 28, 2026 for Zokovea post-exposure prophylaxis. Shionogi stock's prior close was EUR 16.00 on September 30, 2026.

Shionogi, JP3347200002, Illustration mit AI erstellt.

Shionogi (JP3347200002) reported European Commission approval of Zokovea for post-exposure prophylaxis of COVID-19 on September 28, 2026, according to Shionogi. The decision gives the company a fresh regulatory milestone as it builds its infectious-disease portfolio.

What approval means for growth

The commercial importance of Zokovea sits alongside a sharp expansion in Shionogi's fiscal first-quarter figures. A September 8 review of the August 3 results reported revenue of JPY 163.3 billion for the quarter ended June 30, 2026, up 63.70 percent from JPY 99.8 billion a year earlier, while profit attributable to owners rose 148.20 percent to JPY 97.7 billion from JPY 39.4 billion, according to InvestorTrader.

The comparison needs a quality check. The same review linked the increase to business combinations and transfers, including the edaravone business, meaning the 63.70 percent revenue gain does not represent only like-for-like product growth. That distinction matters because integration costs and one-time accounting effects can alter the path from sales to recurring earnings.

Pipeline data arrives in October

Shionogi has also scheduled a broader infectious-disease data presentation at IDWeek from October 21 through October 24, 2026. Business Wire said the program includes 18 additional presentations, an oral presentation from the Phase 3 SCORPIO-PEP study and data on Fetroja and XOCOVA.

For investors, the regulatory approval and the October scientific program point to the same operating theme: infectious diseases remain central to Shionogi's growth strategy. The financial comparison also shows why revenue growth alone is not enough; the first-quarter profit increase was more than twice the revenue growth rate, so the durability of the earnings mix will be important in later periods.

Stock stays below its yearly high

Shionogi was last at JPY 2,766 on the Tokyo Stock Exchange on October 2, 2026 at 11:30 a.m. JST. The quote was JPY 986.00 below the 52-week high of JPY 3,758.00, while the 52-week low was JPY 2,392.50. Global Banking and Finance identifies 4507.T as Shionogi's Tokyo Stock Exchange listing under ISIN JP3347200002 in its reference data.